 |
|
Upcoming Events featuring
National CooperativeRx
|
|
|
Mid-Sized Retirement & Healthcare Plan Management Conference
June 5-8, 2012
Chicago, IL
Learn more
6th Annual Pharmacy Benefits Academy
July 30-August 1, 2012
Rosemont, IL
Learn more
Mid-Sized Retirement & Healthcare Plan Management Conference
September 9-12, 2012
Las Vegas, NV
Learn more
|
|
 |
National CooperativeRx is a not-for-profit coalition founded and owned by plan sponsors to achieve higher value prescription benefits through volume purchasing, clinical solutions, actionable data and unparalleled customer service. For your sales and marketing needs, please contact us at 866-679-9479, extension 223
|
|
|
Health Care Reform Compliance
The Patient Protection and Affordable Care Act includes a list of documents that plan sponsors must provide to plan participants. One newly added document is a Summary of Benefits and Coverage (SBC). To help your plan adhere to providing an SBC, we have attached this link to a PDF from CVS Caremark. Many plans will be required to supply an SBC as soon as September 2012. If you have any questions or need assistance in any way, please don't hesitate to contact us directly at 866-679-9479. |
|
Reuters. After evaluating 500 drug labels in 2009, the US Food and Drug Administration has found that 50% of medication labels are missing dosage and safety information for children. (Pittman, 5/8) Full story
|
NPR. This article highlights the benefits of Value Based Insurance Design for consumers. Big employers are lowering co-pays for chronic diseases such as diabetes in an acknowledgement that if participants take their drugs and stay healthy, it will lower their health care cost down the road. (Andrews, 5/8) Full story
|
|
Forbes. A drug that costs $1.6M? It might already be here. Article author Matthew Herper analyzes how some drugs can cost into the hundreds of thousands of dollars each year, and because some children with terrible diseases are already taking them, these costs could continue to rise in future years. (Herper, 5/1) Full story
|
|
Forbes. Rebates cut about $40B out of the drug industry's sales every year, at least for PBMs. People without drug benefits must pay full price. This article gives insight into the world of rebates, such as the fact that most rebates average around 30% of the original cost. Click into the article for a list of popular drugs and their estimated rebates. (Herper, 5/10) Full story
|
|
Kaiser Health News. Specialty drugs are expensive, and for some patients the cost is rising. A patient's out-of-pocket prescription drug expense often depends solely on the type of plan they have. It may be a simple flat co-pay, it may be a percentage of the drug, and the patient may cap out after paying a certain amount. This article takes a look at specialty drug costs and a deeper look into Value Based Insurance Design. (Andrews, 5/7) Full story
|
|
The Wall Street Journal. The US Food and Drug Administration may support a drug that prevents people from developing HIV. The drug, Truvada, could be administered to people considered at high risk for developing the disease. (5/9) Full story
|
|
Reuters. The U.S. Health and Human Services' Office of Inspector General examined pharmacy billing records from 2009, and flagged about 4% for questionable billing practices for Medicare prescription drug coverage. Most of the flagged pharmacies were independent retail pharmacies. (Krauskopf, 5/10) Full story
|
|
 |
|
